Charles Schwab’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.1K Sell
22,171
-90,770
-80% -$132K ﹤0.01% 3476
2025
Q1
$156K Hold
112,941
﹤0.01% 3289
2024
Q4
$343K Hold
112,941
﹤0.01% 3246
2024
Q3
$562K Hold
112,941
﹤0.01% 3124
2024
Q2
$661K Buy
112,941
+90,837
+411% +$531K ﹤0.01% 3083
2024
Q1
$176K Hold
22,104
﹤0.01% 3252
2023
Q4
$129K Buy
+22,104
New +$129K ﹤0.01% 3328